Hans Gelderblom1 article listing Hans Gelderblom in Nature Communications, indexed by Paperzzz from Crossref and OSF.TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study Nature Communications